3-iodobenzylguanidine has been researched along with astatine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Strickland, DK; Vaidyanathan, G; Zalutsky, MR | 1 |
| Friedman, HS; Strickland, DK; Vaidyanathan, G; Zalutsky, MR | 1 |
| Friedman, HS; Keir, ST; Vaidyanathan, G; Zalutsky, MR | 1 |
| Larsen, RH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
| Cunningham, SH; Mairs, RJ; Vaidyanathan, G; Welsh, PC; Wheldon, TE; Zalutsky, MR | 1 |
| Boyd, M; Mairs, RJ; Wheldon, TE | 1 |
| Babich, J; Boyd, M; Fullerton, NE; Kirk, D; Mairs, RJ; Pimlott, SL; Ross, SC; Zalutsky, MR | 1 |
| Affleck, DJ; Alston, KL; Babich, J; Hens, M; Hunter, DH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG | 1 |
| Batra, V; Carlin, S; Elias, J; Groff, D; Hou, C; Li, Y; Makvandi, M; Maris, JM; Martinez, D; Martorano, P; Pawel, B; Pryma, DA; Ranieri, P; Samanta, M; Tsang, M; Vaidyanathan, G | 1 |
9 other study(ies) available for 3-iodobenzylguanidine and astatine
| Article | Year |
|---|---|
Meta-[211At]astatobenzylguanidine: further evaluation of a potential therapeutic agent.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Biological Transport; Guanidines; Humans; In Vitro Techniques; Iodobenzenes; Mice; Mice, Inbred BALB C; Reserpine; Tetrabenazine; Tissue Distribution; Tumor Cells, Cultured | 1994 |
Meta-[131I]iodobenzylguanidine uptake and meta-[211At]astatobenzylguanidine treatment in human medulloblastoma cell lines.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Biological Transport; Cell Line; Cell Survival; Cerebellar Neoplasms; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Kinetics; Medulloblastoma; Neuroblastoma; Tumor Cells, Cultured | 1995 |
Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Disease Models, Animal; Female; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Binding Sites; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Neuroblastoma; Tissue Distribution; Tumor Cells, Cultured | 1997 |
Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Combined Modality Therapy; Guanidines; Humans; Iodine Radioisotopes; Neuroblastoma; Sodium Iodide; Spheroids, Cellular; Tumor Cells, Cultured | 1998 |
Genetic enhancement of radionuclide cancer therapy.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Astatine; Carrier Proteins; Genetic Therapy; Guanidines; Humans; Neoplasms; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radioisotopes; Radiopharmaceuticals; Symporters; Transfection | 1999 |
Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
Topics: 3-Iodobenzylguanidine; Alpha Particles; Astatine; Beta Particles; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Genetic Therapy; Humans; Iodates; Iodine Radioisotopes; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Structure-Activity Relationship; Symporters; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2005 |
A kit method for the high level synthesis of [211At]MABG.
Topics: 3-Iodobenzylguanidine; Astatine; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Chromatography, Thin Layer; Guanidine; Half-Life; Indicators and Reagents; Isotope Labeling; Quality Control; Radioisotopes; Radiopharmaceuticals; Spectrophotometry, Ultraviolet; Tin | 2007 |
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Alpha Particles; Animals; Astatine; Guanidines; Humans; Iodine Radioisotopes; Mice; Mice, Inbred NOD; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured | 2022 |